Related Experiment Video
Updated: Mar 7, 2026

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Antimicrobial Use for and Resistance of Zoonotic Bacteria Recovered from Nonhuman Primates
Jeffrey Kim1, Dondrae J Coble2, Gregory W Salyards3
1Department of Veterinary Preventive Medicine, College of Veterinary Medicine, College of Public Health, The Ohio State University, Columbus, Ohio.
Abstract:
As a growing threat to human and animal health, antimicrobial resistance (AMR) has become a central public-health topic. Largescale surveillance systems, such as the National Antimicrobial Resistance Monitoring System (NARMS), are now established to monitor and provide guidance regarding AMR, but comprehensive literature on AMR among NHP is sparse. This study provides data regarding current antimicrobial use strategies and the prevalence of AMR in zoonotic bacteria recovered from NHP within biomedical research institutions. We focused on 4 enteric bacteria: Shigella flexneri, Yersinia enterocolitica, Y. pseudotuberculosis, and Campylobacter jejuni. Fifteen veterinarians, 7 biomedical research institutions, and 4 diagnostic laboratories participated, providing susceptibility test results from January 2012 through April 2015. Veterinarians primarily treated cases caused by S. flexneri, Y. enterocolitica, and Y. pseudotuberculosis with enrofloxacin but treated C. jejuni cases with azithromycin and tylosin. All isolates were susceptible to the associated primary antimicrobial but often showed resistance to others. Specifically, S. flexneri isolates frequently were resistant to erythromycin (87.5%), doxycycline (73.7%), and tetracycline (38.3%); Y. enterocolitica isolates to ampicillin (100%) and cefazolin (93.6%); and C. jejuni isolates to methicillin (99.5%) and cephalothin (97.5%). None of the 58 Y. pseudotuber-culosis isolates was resistant to any tested antimicrobial. Notably, resistance patterns were not shared between this study's NHP isolates and human isolates presented by NARMS. Our findings indicate that zoonotic bacteria from NHP diagnostic samples are broadly susceptible to the antimicrobials used to treat the clinical infections. These results can help veterinarians ensure effective antimicrobial therapy and protect staff by minimizing occupational risk.
Insights
Antimicrobial resistance (AMR) in non-human primates (NHP) is understudied. This research found zoonotic bacteria from NHP are generally susceptible to common treatments, aiding veterinary care and staff safety.
Area of Science:
- Veterinary Medicine
- Microbiology
- Public Health
- Antimicrobial Resistance (AMR)
Background:
- Antimicrobial resistance (AMR) poses a significant threat to human and animal health globally.
- Established surveillance systems like the National Antimicrobial Resistance Monitoring System (NARMS) exist, but data on AMR in non-human primates (NHP) is limited.
- Understanding AMR in NHP is crucial due to their role in biomedical research and potential for zoonotic disease transmission.
Purpose of the Study:
- To assess antimicrobial use strategies and the prevalence of AMR in zoonotic bacteria from NHP in research settings.
- To provide data to guide effective antimicrobial therapy in NHP and minimize occupational risks for researchers and veterinarians.
Main Methods:
- Analysis of antimicrobial susceptibility test results for four enteric bacteria (Shigella flexneri, Yersinia enterocolitica, Y. pseudotuberculosis, Campylobacter jejuni) from NHP.
- Data collected from 15 veterinarians, 7 research institutions, and 4 diagnostic labs between January 2012 and April 2015.
- Comparison of resistance patterns between NHP isolates and human isolates from NARMS.
Main Results:
- While isolates were susceptible to primary treatments, significant resistance was observed to other antimicrobials: S. flexneri (erythromycin, doxycycline, tetracycline), Y. enterocolitica (ampicillin, cefazolin), and C. jejuni (methicillin, cephalothin).
- No resistance was found in Y. pseudotuberculosis isolates.
- AMR patterns in NHP isolates did not mirror those found in human isolates reported by NARMS.
Conclusions:
- Zoonotic bacteria recovered from NHP diagnostic samples demonstrate broad susceptibility to antimicrobials used for clinical infections.
- Findings support veterinarians in selecting effective antimicrobial treatments for NHP.
- This data helps mitigate occupational health risks associated with zoonotic bacteria in research environments.
More Related Videos
Related Concept Videos
Antibiotic Selection
Antimicrobial Effectiveness
Development of Antibiotic Resistance

